2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
PHASE3CompletedINTERVENTIONAL
Enrollment
805
Participants
Timeline
Start Date
September 26, 2003
Primary Completion Date
November 24, 2004
Study Completion Date
November 24, 2004
Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG
MK0869, aprepitant
DRUG
Comparator: ondansetron IV
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00090155 - 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED) | Biotech Hunter | Biotech Hunter